To view the PDF file, sign up for a MySharenet subscription.

MEDICLINIC INTERNATIONAL PLC - Mediclinic International plc completes successful refinancing

Release Date: 28/06/2016 16:45
Code(s): MEI     PDF:  
Wrap Text
Mediclinic International plc completes successful refinancing

Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88


MEDICLINIC INTERNATIONAL PLC COMPLETES SUCCESSFUL REFINANCING

Mediclinic International plc (“Mediclinic” or the “Company”), a leading international private healthcare
group, is pleased to announce completion of the refinancing of the Mediclinic Bridge Facility
associated with the Company’s combination with Al Noor Hospitals Group plc.

Summary of new facilities:

-    South African senior bank loan totalling ZAR1.2 billion at an interest rate of JIBAR +1.69%
     with a 3-year term expiring in June 2019
-    South African unsecured preference share funding totalling ZAR1.5 billion at a rate of 73% of
     the prime overdraft interest rate, with a 4-year term expiring in June 2020
-    United Arab Emirates bank loans of USD54.5 million and USD100.0 million at an interest rate
     of LIBOR + 2.75% with respective 4-year and 5-year amortising terms, expiring in June 2020
     and May 2021

The remainder of the GBP266 million drawn down from the Mediclinic Bridge Facility has been
satisfied by a USD64.5 million payment from existing cash resources.

Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom
Website: www.mediclinic.com
JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd


For further information, please contact:

Company Secretary:
Victoria Dalby
Capita Company Secretarial Services Limited
+44 (0)207 954 9600

UK:
Liz Morley /Aarti Iyer/Lucy Stewart
Bell Pottinger
+44 (0)203 772 2468

South Africa:
Tertia Kruger
Mediclinic International
+27 21 809 6500

Notes:

Mediclinic is the world's third largest listed acute hospital operator (outside of the United States), with
three operating platforms in Southern Africa (South Africa and Namibia), Switzerland and the United
Arab Emirates. Its core purpose is to enhance the quality of life of patients by providing cost-effective
acute care specialised hospital services. The group operates 73 hospitals and 45 clinics.
Mediclinic also holds a 29.9% interest in Spire Healthcare, a LSE-listed private healthcare group
based in the UK.


28 June 2016

Date: 28/06/2016 04:45:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story